Newly Created: Clinical Trial Networks Working Group

A Clinical Trial Networks Working Group (CTN WG) was recently established at the GloPID-R General Assembly in Seoul, South Korea on March 17, 2017. This newly created group’s purpose is to have a platform to further exchange information on best practices and lessons learned and find further synergies to work together. The CTN WG’s overarching goal is to support a rapid clinical research response to save populations when epidemics strike.

Chaired by the European Commission, the group has participating representatives from the following networks:

  • APPRISE: Australian Partnership for Preparedness Research on Infectious Diseases Emergencies
  • ISARIC: International Severe Acute Respiratory and emerging Infection Consortium
  • PREPARE: Platform for European Preparedness for Re (emerging) Epidemics
  • REACTing: Research and Action Targeting Emerging Infectious Disease
  • REDe: Research Capacity Network

CTN WG’s work will focus on incorporating a social sciences approach; capacity building; data sharing; and ethical, administrative, regulatory and legal (EARL) barriers to research. To that end, the group intends to share resources on the GloPID-R website starting with a webinar series:

  • the use of social sciences in clinical trials
  • capacity building activities of the networks
  • data sharing experiences in the different networks

The webinar on data sharing is organized in collaboration with the GloPID-R working group on data sharing in public health emergencies.

Future projects are under discussion as the group maps the current activities and identifies potential areas of collaboration.


Evelyn Depoortere

Read more on the CTN WG

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.